1. Academic Validation
  2. Homochiral Covalent Organic Framework for Catalytic Asymmetric Synthesis of a Drug Intermediate

Homochiral Covalent Organic Framework for Catalytic Asymmetric Synthesis of a Drug Intermediate

  • J Am Chem Soc. 2020 Jul 22;142(29):12574-12578. doi: 10.1021/jacs.0c04722.
Hui-Chao Ma 1 Gong-Jun Chen 1 Fang Huang 1 Yu-Bin Dong 1
Affiliations

Affiliation

  • 1 College of Chemistry, Chemical Engineering and Materials Science, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Shandong Normal University, Jinan 250014, P. R. China.
Abstract

(S)-2-(2-Chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetonitrile ((S)-CIK) is a key intermediate in the synthesis of (S)-clopidogrel, which is one of the most saleable worldwide antiplatelet and antithrombotic drugs. We show herein a facile method for the direct synthesis of (S)-CIK via Strecker reaction using a homochiral covalent framework catalyst in a heterogeneous way. The asymmetric synthesis involves a photothermal-conversion-triggered, thermally driven reaction which affords (S)-CIK in 98% yield with 94% enantiomeric excess under visible-light irradiation. Furthermore, the above approach is readily extended to a gram-scale level on a fixed-bed continuous-flow model reactor. The potential utility of this strategy is highlighted by the preparation of many more Other types of chiral drugs and drug intermediates in a green and facile way.

Figures